Search / 371 results found

  • Updated

ANDOVER, Mass., Dec. 22, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming 40th Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 12, 2022, at 7:30 a.m. Eastern Standard Time.